-+ 0.00%
-+ 0.00%
-+ 0.00%

PolyPid Agrees With ADVANZ PHARMA To Terminate Their 2022 Exclusive License, Distribution And Supply Agreement For D-PLEX₁₀₀ In Europe

Benzinga·10/01/2026 13:11:08
Listen to the news

As a result, the exclusive European commercialization rights for D-PLEX₁₀₀ have reverted to PolyPid.